Yestar Healthcare (HKG:2393) is considering forming a joint venture in Singapore with oncology platform New Genetron and potentially developing business in Indonesia, Malaysia, and Singapore, a Monday Hong Kong bourse filing said.

The JV, which intends to incorporate a new entity in Indonesia, will build and run clinical molecular diagnostics laboratories with a focus on precision oncology.

Another area of focus will be establishing local production facilities for IVD reagents and kits where appropriate, according to the healthcare consumables and equipment company.

The laboratories will offer early cancer screening, comprehensive genomic profiling, minimal residual disease monitoring, and non-invasive prenatal testing.